Listing 1 - 4 of 4 |
Sort by
|
Choose an application
Ensuring microbiological safety in the food (of animal origin) chain is a challenging task due to the complex interactions among animals, humans and the environment. However, technological and analytical advances in recent years have provided a broader insight into microbiological hazards in the food chain and risk assessment. The objective of the proposed Special Issue “Study of Microbiological Safety in the Food Chain” was therefore to obtain scientific papers addressing microbiological hazards in the food chain, such as bacterial antimicrobial resistance, bacterial or fungal spoilage of foods, the antimicrobial potential of the indigenous microbiota, the aminogenic or amine-reducing capacity of the microbiota, and papers that apply novel methods to study the food microbiome to discover potential, previously unknown microbial hazards. This Special Issue of the journal Processes entitled “Study of Microbiological Safety in the Food Chain” consists of nine research papers and one review paper. Four papers focus on the microbiological aspects of milk and dairy products, three on meat and meat products, two on eggs, and one on various market foods. The microorganisms of interest were species of lactobacilli, enterococci and molds, Yersinia enterocolitica, Bacillus cereus and the general microbiota in certain foods.
Humanities --- Social interaction --- antimicrobial resistance --- Lactobacillus johnsonii --- Lactobacillus zeae --- MALDI-TOF-MS --- milk --- PCR --- mold --- egg --- Penicillium --- colony morphology --- Ehrlich reaction --- creatine --- restriction enzyme --- PCR-ITS-RFLP --- egg quality --- Cladosporium --- Fusarium --- raw goat milk --- enterococcal species --- safety --- virulence factor --- bacteriocins --- meat safety --- biological hazards --- Yersinia enterocolitica --- Toxoplasma gondii --- food chain information --- emerging foodborne pathogens --- Bacillus --- probiotics --- ewe --- milk lump cheese --- microbiome --- microbial flora --- dry aged beef --- rancidity --- index --- meat products --- dry-cured hams --- sensory evaluation --- surface moulds --- Aspergillus --- Croatian regions --- biogenic amines --- enterococci --- lactobacilli --- lactococci --- ripened cheese --- n/a
Choose an application
Ensuring microbiological safety in the food (of animal origin) chain is a challenging task due to the complex interactions among animals, humans and the environment. However, technological and analytical advances in recent years have provided a broader insight into microbiological hazards in the food chain and risk assessment. The objective of the proposed Special Issue “Study of Microbiological Safety in the Food Chain” was therefore to obtain scientific papers addressing microbiological hazards in the food chain, such as bacterial antimicrobial resistance, bacterial or fungal spoilage of foods, the antimicrobial potential of the indigenous microbiota, the aminogenic or amine-reducing capacity of the microbiota, and papers that apply novel methods to study the food microbiome to discover potential, previously unknown microbial hazards. This Special Issue of the journal Processes entitled “Study of Microbiological Safety in the Food Chain” consists of nine research papers and one review paper. Four papers focus on the microbiological aspects of milk and dairy products, three on meat and meat products, two on eggs, and one on various market foods. The microorganisms of interest were species of lactobacilli, enterococci and molds, Yersinia enterocolitica, Bacillus cereus and the general microbiota in certain foods.
antimicrobial resistance --- Lactobacillus johnsonii --- Lactobacillus zeae --- MALDI-TOF-MS --- milk --- PCR --- mold --- egg --- Penicillium --- colony morphology --- Ehrlich reaction --- creatine --- restriction enzyme --- PCR-ITS-RFLP --- egg quality --- Cladosporium --- Fusarium --- raw goat milk --- enterococcal species --- safety --- virulence factor --- bacteriocins --- meat safety --- biological hazards --- Yersinia enterocolitica --- Toxoplasma gondii --- food chain information --- emerging foodborne pathogens --- Bacillus --- probiotics --- ewe --- milk lump cheese --- microbiome --- microbial flora --- dry aged beef --- rancidity --- index --- meat products --- dry-cured hams --- sensory evaluation --- surface moulds --- Aspergillus --- Croatian regions --- biogenic amines --- enterococci --- lactobacilli --- lactococci --- ripened cheese --- n/a
Choose an application
Ensuring microbiological safety in the food (of animal origin) chain is a challenging task due to the complex interactions among animals, humans and the environment. However, technological and analytical advances in recent years have provided a broader insight into microbiological hazards in the food chain and risk assessment. The objective of the proposed Special Issue “Study of Microbiological Safety in the Food Chain” was therefore to obtain scientific papers addressing microbiological hazards in the food chain, such as bacterial antimicrobial resistance, bacterial or fungal spoilage of foods, the antimicrobial potential of the indigenous microbiota, the aminogenic or amine-reducing capacity of the microbiota, and papers that apply novel methods to study the food microbiome to discover potential, previously unknown microbial hazards. This Special Issue of the journal Processes entitled “Study of Microbiological Safety in the Food Chain” consists of nine research papers and one review paper. Four papers focus on the microbiological aspects of milk and dairy products, three on meat and meat products, two on eggs, and one on various market foods. The microorganisms of interest were species of lactobacilli, enterococci and molds, Yersinia enterocolitica, Bacillus cereus and the general microbiota in certain foods.
Humanities --- Social interaction --- antimicrobial resistance --- Lactobacillus johnsonii --- Lactobacillus zeae --- MALDI-TOF-MS --- milk --- PCR --- mold --- egg --- Penicillium --- colony morphology --- Ehrlich reaction --- creatine --- restriction enzyme --- PCR-ITS-RFLP --- egg quality --- Cladosporium --- Fusarium --- raw goat milk --- enterococcal species --- safety --- virulence factor --- bacteriocins --- meat safety --- biological hazards --- Yersinia enterocolitica --- Toxoplasma gondii --- food chain information --- emerging foodborne pathogens --- Bacillus --- probiotics --- ewe --- milk lump cheese --- microbiome --- microbial flora --- dry aged beef --- rancidity --- index --- meat products --- dry-cured hams --- sensory evaluation --- surface moulds --- Aspergillus --- Croatian regions --- biogenic amines --- enterococci --- lactobacilli --- lactococci --- ripened cheese --- antimicrobial resistance --- Lactobacillus johnsonii --- Lactobacillus zeae --- MALDI-TOF-MS --- milk --- PCR --- mold --- egg --- Penicillium --- colony morphology --- Ehrlich reaction --- creatine --- restriction enzyme --- PCR-ITS-RFLP --- egg quality --- Cladosporium --- Fusarium --- raw goat milk --- enterococcal species --- safety --- virulence factor --- bacteriocins --- meat safety --- biological hazards --- Yersinia enterocolitica --- Toxoplasma gondii --- food chain information --- emerging foodborne pathogens --- Bacillus --- probiotics --- ewe --- milk lump cheese --- microbiome --- microbial flora --- dry aged beef --- rancidity --- index --- meat products --- dry-cured hams --- sensory evaluation --- surface moulds --- Aspergillus --- Croatian regions --- biogenic amines --- enterococci --- lactobacilli --- lactococci --- ripened cheese
Choose an application
The discovery of new drugs is one of pharmaceutical research's most exciting and challenging tasks. Unfortunately, the conventional drug discovery procedure is chronophagous and seldom successful; furthermore, new drugs are needed to address our clinical challenges (e.g., new antibiotics, new anticancer drugs, new antivirals).Within this framework, drug repositioning—finding new pharmacodynamic properties for already approved drugs—becomes a worthy drug discovery strategy.Recent drug discovery techniques combine traditional tools with in silico strategies to identify previously unaccounted properties for drugs already in use. Indeed, big data exploration techniques capitalize on the ever-growing knowledge of drugs' structural and physicochemical properties, drug–target and drug–drug interactions, advances in human biochemistry, and the latest molecular and cellular biology discoveries.Following this new and exciting trend, this book is a collection of papers introducing innovative computational methods to identify potential candidates for drug repositioning. Thus, the papers in the Special Issue In Silico Strategies for Prospective Drug Repositionings introduce a wide array of in silico strategies such as complex network analysis, big data, machine learning, molecular docking, molecular dynamics simulation, and QSAR; these strategies target diverse diseases and medical conditions: COVID-19 and post-COVID-19 pulmonary fibrosis, non-small lung cancer, multiple sclerosis, toxoplasmosis, psychiatric disorders, or skin conditions.
Medicine --- Pharmaceutical industries --- COVID-19 --- drug repurposing --- topological data analysis --- persistent Betti function --- SARS-CoV-2 --- network-based pharmacology --- combination therapy --- nucleoside GS-441524 --- fluoxetine --- synergy --- antidepressant --- natural compounds --- QSAR --- molecular docking --- drug repositioning --- UK Biobank --- vaccine --- LC-2/ad cell line --- drug discovery --- docking --- MM-GBSA calculation --- molecular dynamics --- cytotoxicity assay --- GWAS --- multiple sclerosis --- oxidative stress --- repurposing --- ADME-Tox --- bioinformatics --- complex network analysis --- modularity clustering --- ATC code --- hidradenitis suppurativa --- acne inversa --- transcriptome --- proteome --- comorbid disorder --- biomarker --- signaling pathway --- druggable gene --- drug-repositioning --- MEK inhibitor --- MM/GBSA --- Glide docking --- MD simulation --- MM/PBSA --- single-cell RNA sequencing --- pulmonary fibrosis --- biological networks --- p38α MAPK --- allosteric inhibitors --- in silico screening --- computer-aided drug discovery --- network analysis --- psychiatric disorders --- medications --- psychiatry --- mental disorders --- toxoplasmosis --- Toxoplasma gondii --- in vitro screening --- drug targets --- drug-disease interaction --- target-disease interaction --- DPP4 inhibitors --- lipid rafts
Listing 1 - 4 of 4 |
Sort by
|